Most pharma companies are not ‘future ready’ as pressure mounts from AI advances and IRA legislation, survey finds
Pharma is not ready for the future. Only 10% say they’re “future ready,” according to a recent survey of pharmaceutical leaders by Indegene. That’s a big decline from just two years ago when close to 60% told the commercial consulting group they felt well prepared for the future.
What’s causing all the uncertainty? Two key changes — the emergence of generative AI and the passage of the Inflation Reduction Act — are disrupting pharma management peace of mind.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.